No abstract available
Keywords:
cancer outcome; perioperative management; postoperative complication; prehabilitation; prognosis.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Editorial on the Research Topic Perioperative management and cancer outcome
References
-
-
Nguyen J, Luk K, Vang D, Soto W, Vincent L, Robiner S, et al. . Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Br J Anaesth (2014) 113(Suppl 1):i4–13. doi: 10.1093/bja/aeu090
-
DOI
-
PMC
-
PubMed
-
-
Du KN, Feng L, Newhouse A, Mehta J, Lasala J, Mena GE, et al. . Effects of intraoperative opioid use on recurrence-free and overall survival in patients with esophageal adenocarcinoma and squamous cell carcinoma. Anesth Analg (2018) 127(1):210–6. doi: 10.1213/ANE.0000000000003428
-
DOI
-
PubMed
-
-
Howard R, Yin YS, McCandless L, Wang S, Englesbe M, MaChado-Aranda D. Taking control of your surgery: impact of a prehabilitation program on major abdominal surgery. J Am Coll Surg (2019) 228(1):72–80. doi: 10.1016/j.jamcollsurg.2018.09.018
-
DOI
-
PMC
-
PubMed
-
-
Trepanier M, Minnella EM, Paradis T, Awasthi R, Kaneva P, Schwartzman K, et al. . Improved disease-free survival after prehabilitation for colorectal cancer surgery. Ann Surg (2019) 270(3):493–501. doi: 10.1097/SLA.0000000000003465
-
DOI
-
PubMed
-
-
Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol (2016) 70:395–411. doi: 10.1146/annurev-micro-102215-095513
-
DOI
-
PMC
-
PubMed